Sheffield Teaching Hospitals NHS Foundation Trust, UK.
Nephron Clin Pract. 2013;125(1-4):275-94. doi: 10.1159/000360033. Epub 2014 Feb 14.
Dialysis access should be timely, minimise complications and maintain functionality. Good functional access is required for renal replacement therapy (RRT) to be successful. The aim of the combined vascular and peritoneal dialysis access audit was to examine practice patterns with respect to dialysis access and highlight variations in practice between renal centres.
The UK Renal Registry collected centre-specific information on vascular and peritoneal access outcome measures including patient demographics, dialysis access type (at start of dialysis and three months after start of dialysis), surgical assessment and access functionality. The combined access audit covered incident haemodialysis (HD) and peritoneal dialysis (PD) patients in 2012 from England, Northern Ireland and Wales. Centres who had reported data on incident PD patients for the previous audit in 2011 were additionally asked to provide one year follow up data for this group.
Fifty-one centres in England, Wales and Northern Ireland (representing 82% of all centres) returned data on first access from 3,720 incident HD patients and 1,018 incident PD patients. A strong relationship was seen between surgical assessment and the likelihood of starting HD with an arteriovenous fistula (AVF). Type of first access was related to the length of time known to renal services with higher numbers of AVFs and PD catheters used in patients known to renal services for at least one year. Three month and one year outcomes of HD and PD access were poorly reported.
This audit provides information on important patient related outcome measures with the potential to lead to an improvement in access provision. This represents an important advance, however data collection remains suboptimal. There is wide practice variation across the England, Wales and Northern Ireland in provision of both HD and PD access which requires further exploration.
透析通路应及时建立,尽量减少并发症并保持功能。良好的功能性通路是肾替代治疗(RRT)成功的必要条件。本次联合血管和腹膜透析通路审核旨在检查透析通路的实践模式,并强调各肾脏中心之间的实践差异。
英国肾脏登记处收集了有关血管和腹膜通路结局指标的中心特定信息,包括患者人口统计学数据、透析通路类型(开始透析时和开始透析后三个月)、手术评估和通路功能。本次联合通路审核涵盖了 2012 年英格兰、北爱尔兰和威尔士的新发生血液透析(HD)和腹膜透析(PD)患者。之前在 2011 年进行的审核中已经报告了新发生 PD 患者数据的中心,被要求另外提供这一组患者的一年随访数据。
来自英格兰、威尔士和北爱尔兰的 51 个中心(占所有中心的 82%)报告了 3720 例新发生 HD 患者和 1018 例新发生 PD 患者的首次通路数据。手术评估与开始 HD 时使用动静脉瘘(AVF)的可能性之间存在很强的关系。首次通路的类型与患者在肾脏服务中已知的时间长度有关,在肾脏服务中已知至少一年的患者中,使用的 AVF 和 PD 导管数量更高。HD 和 PD 通路的 3 个月和 1 年结局报告不佳。
本次审核提供了有关重要患者相关结局指标的信息,有可能改善通路的提供。这是一个重要的进步,然而数据收集仍不理想。在英格兰、威尔士和北爱尔兰,HD 和 PD 通路的提供存在广泛的实践差异,需要进一步探索。